We are monitoring the impact of COVID-19 & Recession alarm on MEA Antinuclear Antibody Test Market Get in touch with us for detailed analysis Know More
Share on

Middle East And Africa Antinuclear Antibody Test Market Research Report - Segmented By Disease, Technique, Product, End User & By Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 3174
Pages: 145

MEA Antinuclear Antibody Test Market Size & Growth (2022 to 2027):

As per the research report, the size of the Middle East and Africa Antinuclear Antibody Test Market is valued at USD 72.82 million in 2022 and expected to reach USD 116.75 million by 2027 at a CAGR of 9.90% during the forecast period 2022 to 2027.

The market is showcasing evident potential in the mentioned forecasting period. The antinuclear antibody test is a primary test to check a person’s autoimmune disorders. Autoimmune disorders can affect many tissues and organs in the body. This test is most often used to diagnose the Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis.

Factors such as an increase in the prevalence of autoimmune diseases, such as rheumatoid arthritis and SLE, growing economies in this region and growth in the awareness of people about these diseases, are driving this market. Autoimmune diseases can also cause type I diabetes. Other factors such as, increase in healthcare expenditure of people due to growing economies, and government healthcare insurance & reimbursement policies are fuelling this market. On the other hand, factors such as poor economies in this region, war regions, diagnostic errors, product approval, and unavailability of skilled labor are hindering the growth of this market.

This research report on the MEA Antinuclear Antibody Test Market has been segmented and sub-segmented into the following categories:

By Disease:

  • SLE
  • Rheumatoid Arthritis

By Technique:

  • Immunofluorescence
  • Multiplex
  • ELISA

By Product:

  • Software
  • Systems
  • Services
  • Reagents
  • Assay Kits

By End User:

  • Hospitals
  • Clinical Labs

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

The Middle East and Africa. Africa is growing at a faster rate compared to the Middle East. Because of being affected by wars and most of the countries have poor economies, the market is not that big in this region. Because of very few competitors in this region, opportunities for the new and upcoming companies are huge.

The leading companies leading in the MEA Antinuclear Antibody Test Market profiled in the report are  Zeus Scientific Inc., Inova Diagnostics, Immuno Concepts, Euroimmun AG, Antibodies Inc., Thermo Fisher Scientific inc., Trinity Biotech plc, ERBA Diagnostics Inc., Bio-Rad Laboratories Inc., and Alere Inc.

1.Introduction           

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases                      

         2.2.1 Secondary Research           

         2.2.2 Primary Research 

         2.2.3 Econometric Modelling      

         2.2.4 Expert Validation  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary                

                3.2 Key Inferences  

                3.3 Epidemology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints                    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation

                5.1 Disease 

         5.1.1 Introduction           

         5.1.2 SLE              

         5.1.3 Rheumatoid Arthritis          

         5.1.4  Y-o-Y Growth Analysis, By Disease               

         5.1.5  Market Attractiveness Analysis, By Disease             

         5.1.6  Market Share Analysis, By Disease              

                5.2 Technique                   

         5.2.1 Introduction           

         5.2.2 Immunofluorescence         

         5.2.3 Multiplex 

         5.2.4 ELISA         

         5.2.5 Y-o-Y Growth Analysis, By Technique          

         5.2.6 Market Attractiveness Analysis, By Technique        

         5.2.7 Market Share Analysis, By Technique          

                5.3 Product 

         5.3.1 Introduction           

         5.3.2 Software  

         5.3.3 Systems   

         5.3.4 Services    

         5.3.5 Reagents & Assay Kits        

         5.3.6 Y-o-Y Growth Analysis, By Product               

         5.3.7  Market Attractiveness Analysis, By Product            

         5.3.8  Market Share Analysis, By Product              

                5.4 End-User                     

         5.4.1 Introduction           

         5.4.2 Hospitals  

         5.4.3 Clinical Labs             

         5.4.4 Y-o-Y Growth Analysis, By End-User            

         5.4.5  Market Attractiveness Analysis, By End-User         

         5.4.6  Market Share Analysis, By End-User           

6. Geographical Analysis                       

                6.1 Introduction        

         6.1.1 Regional Trends    

         6.1.2 Impact Analysis     

         6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Disease

  6.1.3.3 By Technique

  6.1.3.4 By Product

  6.1.3.5 By End-User

         6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Disease

  6.1.4.3 By Technique

  6.1.4.4 By Product

  6.1.4.5 By End-User

         6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Disease

  6.1.5.3 By Technique

  6.1.5.4 By Product

  6.1.5.5 By End-User

                6.2 Middle-East         

                6.3 Africa     

7.Strategic Analysis                 

                7.1 PESTLE analysis  

         7.1.1 Political     

         7.1.2 Economic 

         7.1.3 Social         

         7.1.4 Technological         

         7.1.5 Legal          

         7.1.6 Environmental       

                7.2 Porter’s Five analysis       

         7.2.1 Bargaining Power of Suppliers        

         7.2.2 Bargaining Power of Consumers    

         7.2.3 Threat of New Entrants     

         7.2.4 Threat of Substitute Products and Services              

         7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                  

                8.1 Zeus Scientific Inc.                   

         8.1.1 Overview 

         8.1.2 Product Analysis   

         8.1.3 Financial analysis  

         8.1.4 Recent Developments       

         8.1.5 SWOT analysis       

         8.1.6 Analyst View          

                8.2 Inova Diagnostics                     

                8.3 Immuno Concepts                   

                8.4 Euroimmun AG  

                8.5 Antibodies Inc.   

                8.6 Thermo Fisher Scientific Inc.        

                8.7 Trinity Biotech plc                    

                8.8 ERBA Diagnostics Inc.      

                8.9 Bio-Rad Laboratories Inc.                      

                8.10 Alere Inc.                  

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures       

 

  1. Middle East & Africa Antinuclear Antibody Testing Market By Disease, From 2022 - 2027 ( USD Million )
  2. Middle East & Africa SLE Market By Region, From 2022 - 2027 ( USD Million )
  3. Middle East & Africa Rheumatoid Arthritis Market By Region, From 2022 - 2027 ( USD Million )
  4. Middle East & Africa Antinuclear Antibody Testing Market By Technique, From 2022 - 2027 ( USD Million )
  5. Middle East & Africa Immunofluorescence Market By Region, From 2022 - 2027 ( USD Million )
  6. Middle East & Africa Multiplex Market By Region, From 2022 - 2027 ( USD Million )
  7. Middle East & Africa ELISA Market By Region, From 2022 - 2027 ( USD Million )
  8. Middle East & Africa Antinuclear Antibody Testing Market By Product, From 2022 - 2027 ( USD Million )
  9. Middle East & Africa Software Market By Region, From 2022 - 2027 ( USD Million )
  10. Middle East & Africa Systems Market By Region, From 2022 - 2027 ( USD Million )
  11. Middle East & Africa Services Market By Region, From 2022 - 2027 ( USD Million )
  12. Middle East & Africa Reagents & Assay Kits Market By Region, From 2022 - 2027 ( USD Million )
  13. Middle East & Africa Antinuclear Antibody Testing Market By End-Users, From 2022 - 2027 ( USD Million )
  14. Middle East & Africa Hospitals Market By Region, From 2022 - 2027 ( USD Million )
  15. Middle East & Africa Clinical Labs Market By Region, From 2022 - 2027 ( USD Million )
  16. Middle East Antinuclear Antibody Testing Market By Disease, From 2022 - 2027 ( USD Million )
  17. Middle East Antinuclear Antibody Testing Market By Technique, From 2022 - 2027 ( USD Million )
  18. Middle East Antinuclear Antibody Testing Market By Product, From 2022 - 2027 ( USD Million )
  19. Middle East Antinuclear Antibody Testing Market By End-Users, From 2022 - 2027 ( USD Million )
  20. Africa Antinuclear Antibody Testing Market By Disease, From 2022 - 2027 ( USD Million )
  21. Africa Antinuclear Antibody Testing Market By Technique, From 2022 - 2027 ( USD Million )
  22. Africa Antinuclear Antibody Testing Market By Product, From 2022 - 2027 ( USD Million )
  23. Africa Antinuclear Antibody Testing Market By End-Users, From 2022 - 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample